48 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... Diabetes #Diabetic #Medications ... #Dosing #Renal ... #Impairment #CKD ... #Table #GFR #Hypoglycemics
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Antihypertensive Medications ... Dissection • CKD ... Antihypertensive #Medications ... #pharmacology #table ... #management
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Adjusted Pain Medication ... Dosing based on ... GFR #Renal #Dosing ... Pharmacology #Opiates #CKD ... #Gabapentin #Table
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Diabetes Type 2 Medication ... Management and ... Titration Algorithm ... Established ASCVD or CKD ... #Management #Algorithm
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
prophylaxis #VTE #DVT #dosing ... #Medications #management ... #indications #pharmacology ... #table
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Assessment and Management ... #Management # ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Assessment and Management ... - Transdermal Medications ... #Management # ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Assessment and Management ... #Management # ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... Improved outcomes in CKD ... #table #comparison ... #management #endocrinology
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Assessment and Management ... Neuropathic Pain Medications ... #Neuropathic #Medications ... #Doses #Dosing ... #Table #PAMI